The Technical AnalystExchange: JKT Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
PT Indofarma Tbk Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.75% IDR135.00
America/New_York / 3 mai 2024 @ 05:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 418 401 mill |
| EPS: | -141.02 |
| P/E: | -0.960 |
| Earnings Date: | Apr 28, 2024 |
| SharesOutstanding: | 3 099.27 mill |
| Avg Daily Volume: | 0.198 mill |
| RATING 2024-05-03 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Sell | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Sell | |
| DE: | Strong Sell | |
| P/E: | Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.960 | sector: PE 65.62 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.06x |
| Company: PE -0.960 | industry: PE 16.03 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
IDR 117.59 - 152.41 ( +/- 12.89%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | IDR135.00 (0.75% ) |
| Volume | 0.0409 mill |
| Avg. Vol. | 0.198 mill |
| % of Avg. Vol | 20.66 % |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For INAF.JK
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
INAF.JK
PT Indofarma Tbk, together with its subsidiaries, manufactures and markets pharmaceutical products in Indonesia. The company trades in and distributes drugs, medical devices, medical supplies, extracts, and herbals; and operates laboratory. It also provides COVID-19 test services, including rapid diagnostic test antigen; reverse transcription polymerase chain reaction, and genose. The company also exports its products. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is headquartered in Bekasi, Indonesia. PT Indofarma Tbk operates as a subsidiary of PT. Bio Farma.